Navigation Links
Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease
Date:5/20/2010

Through Existence’s cutting-edge technological advancements, prediction and prevention of a wide range of both common and rare diseases are possible before they ever manifest. The future of medicine starts today.

(PRWEB) May 20, 2010 -- Welcome your new Existence! Existence Genetics LLC, the world’s first predictive medicine company, is working with healthcare providers to PREDICT, PREVENT, and PREVAIL over disease.

Founded in 2005 by a team of physicians, Existence Genetics is pioneering the field of predictive medicine by providing Genetically Tailored Technology to the health care industry. Existence provides health care professionals with access to groundbreaking predictive medicine services and delivers understandable, useful, and personalized solutions to protect and preserve their patients’ health. Rather than simply handing bewildering results to an untrained patient, the goal of Existence is to empower health care professionals with genetic technology so that they can efficiently integrate genetic screening into their practice and provide cutting-edge predictive medicine services to their patients. Because of this, Existence provides its services only through health care professionals and not direct to the consumer (DTC) or over the counter (OTC).

Existence has developed patent-pending Nexus technologies to enable comprehensive genetic testing and analysis that focuses on the personalized prevention of disease. The Nexus technologies include a proprietary, highly advanced gene chip known as the Nexus Gene Chip. This first-of-its-kind, highly accurate gene chip allows cost-effective, time-efficient screening for hundreds of potential disease predispositions as well as for genes that are involved in the prevention and treatment of disease, thereby enabling the advent of genetically tailored prevention. The results provided by the Nexus Gene Chip are analyzed by the Nexus IT system, which uses patent-pending technologies such as the disease matrix, reflex analysis, panel screening, and next-generation genetic reports to provide health care professionals with straightforward, genetically-tailored solutions for their patients.

Existence’s Nexus technologies make predictive medicine straightforward, understandable, useful, and personalized. Existence’s One Genome philosophy means that we focus on all diseases regardless of their prevalence and screen simultaneously for hundreds of rare and common diseases. And because its Nexus technologies were developed with this philosophy in mind, Existence will be the first company that is able to provide full genome clinical analysis of full genome sequencing data.

In addition, Existence’s newest technology, the Pythia Approach, which is now in its final stages of development, combines the genetic analysis of two potential parents to determine the disease predispositions and traits their yet-to-be-conceived offspring are likely to inherit.

Through Existence’s cutting-edge technological advancements, prediction and prevention of a wide range of both common and rare diseases are possible before they ever manifest. The future of medicine starts today.

Existence Genetics has offices in California and New York, with headquarters in Los Angeles. To learn more about Existence Genetics and the Nexus technologies, visit www.existencegenetics.com.

###

Read the full story at http://www.prweb.com/releases/existencegenetics/may2010/prweb4025124.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Georgia DUI Lawyers Scramble to Publicize Existence of New Appeal Fee of $150 for All DUI-Related Administrative License Suspension Cases
2. Medco Acquires Leading Genetics Healthcare Company, DNA Direct
3. New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies
4. Chicago Cancer Genome Project studies genetics of 1,000 tumors
5. Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York
6. Interleukin Genetics, Inc. and Stanford University Report Genetic Test Improves Weight Loss Success With Diets
7. Study finds changes in fetal epigenetics throughout pregnancy
8. Genetics, Psychology May Trigger ADHD
9. Resveratrol Supplement Company RevGenetics Welcomes New Chief Science Officer
10. Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health
11. Cancer genetics pioneer wins Margaret Kripke Legend Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Existence Genetics is Pioneering the Field of Predictive Medicine -  Nexus Technologies Critical in Understanding and Preventing Deadly Disease 
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... Old School ... boxing champ Ashley Theophane as a new Brand Ambassador. Theophane, who trained with Floyd ... welterweight title in 2011. He has racked up an impressive number of wins in ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... solution provider, today announced that its digital marketing solutions have enabled Children’s Hospital ... investment in 24 months. , Recognizing the value of a digital marketing ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... into a research collaboration to translate advances in basic neuroscience at the BMRI ... and beyond. The collaboration seeks to improve movement, vision, and cognition impaired by stroke, ...
(Date:3/22/2017)... Norwich, NY (PRWEB) , ... March 22, 2017 , ... ... to communities in the greater Nassau County region, is embarking on a combined charity ... breast cancer. , For the last 25 years, the Great Neck Breast Cancer ...
(Date:3/22/2017)... NC (PRWEB) , ... March 22, 2017 , ... Chris ... assistance to families and business professionals throughout the coastal plains region, is initiating a ... to overcome cancer. , Dillyn was first diagnosed with leukemia on a Friday evening ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... -- Kalorama Information has noted five news developments in ... industry.  This month the FDA granted a CLIA waiver to ... market has reached $18.4 billion in sales and continues ... battle and the acquisition by Abbott is still in ... chemistry analyzer and researchers evaluated fetal fibronectin screening for ...
(Date:3/22/2017)... , March 22, 2017 NetworkNewsWire Editorial ... ... given differing statements by White House officials. Federal laws are ... marijuana for medical and/or recreational use, and businesses like SinglePoint, ... Inc. (NASDAQ: CRBP), Medical Marijuana, Inc. (OTC: MJNA), Cannabis Science, ...
(Date:3/22/2017)... March 22, 2017  Based on its recent ... & Sullivan recognizes GE Healthcare with the 2016 ... Award. GE Healthcare,s strategy of innovating and expanding ... allowed it to effectively compete in a mature, ... In addition to aiding patient and clinician workflows, ...
Breaking Medicine Technology: